Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
68 Cards in this Set
- Front
- Back
What are high levels of creatine kinase in serum an indication of?
|
Muscular dystrophy
|
|
Enzymes alter the _____ of the reaction not the ____ ____
|
Enzymes alter the rate of the reaction not the equilibrium constant
|
|
How fast do enzymes work?
|
Increases rate between 10^8 to 10^12
|
|
What is the enzymatic turnover number (moles product/moles active site/sec)
|
~20 per second
|
|
____ and ___ usually stay tightly bound to the enzyme
|
FAD and FMN
|
|
What is the cofactor that reversibly binds to an enzyme
|
NADH
|
|
Active site
|
The region of the enzyme where chemical reaction occurs.
|
|
Allosteric
|
"other" then the active site
|
|
Oxidoreductase
|
Oxidation-reduction reaction
|
|
CH3CH2OH -> CH3CHO
|
Oxidation-reduction reaction
|
|
Transferase
|
Transfer of a group (eg PO4)
|
|
Hydrolase
|
Addition of water, cleavage
|
|
Lyase
|
Cleavage by elimination
|
|
Isomerase
|
Cause of isomerization
|
|
Ligase
|
Coupling two molecules, ATP hydrolysis
|
|
What are the two types of bisubstrate reactions?
|
Random (By-By) and Ordered (Ping-Pong)
|
|
How are most pathways regulated?
|
Via an irreversible step
|
|
What is the rate determining step?
|
The slowest step
|
|
What are the types of catalysis?
|
Acid-base, covalent, metal ion, proximity and orientation, transition state stabilization, electrostatic effects
|
|
What are metalloenzymes?
|
The metal remains tightly bound to the enzyme. FE2+, FE3+, Cu, Zn, Mg, Co
|
|
What metals do enzymes not remain tightly bound?
|
Na, K, Mg, Ca
|
|
What is transition state binding?
|
The binding of substrates to the active site promotes straining so that the transition state is formed, these generally bind more tightly to enzymes.
These often make good therapeutic agents. |
|
What is electrostatic catalysis?
|
The distribution of charges in an active site, which influences the stability of the transition state and the pKa of amino acid side chains.
|
|
What is a reversible enzyme inhibitor?
|
Inhibitor binds reversibly to enzymes (binding may be tight and seem irreversible under physiological conditions)
|
|
What is an irreversible enzyme inhibitor?
|
Inhibitor reacts covalently with the enzyme
|
|
What are the types of reversible inhibition?
|
Competitive, non-competitive, uncompetitive, and mixed
|
|
What is competitive inhibition?
|
Competes with substrate for binding to the enzyme, causing an increase in Km. Often binds to same site as the substrate and resembles the substrate.
|
|
What is non-competitive inhibition?
|
Only Vmax changes
|
|
What is mixed inhibition?
|
Both Km and Vmax change
|
|
How does penicillin work?
|
Inhibits an enzyme involved in the synthesis of bacterial cell walls
|
|
How does aspirin work?
|
Inhibits (acetylates) prostaglandin synthesis (cyclooxygenase)
|
|
What are two examples of the rational drug design?
|
HIV protease inhibitors and Celebrex (COX II inhibitor)
|
|
What does Amanitin inhibit?
|
RNA polymerase II
|
|
Can enzymes be made of RNA?
|
Yes
|
|
What is the active site
|
site on enzyme where chemical change occurs
|
|
What is the substrate
|
molecule that the enzyme modifies
|
|
What is the product?
|
molecule that the enzyme produces
|
|
What is a cofactor
|
a small molecule required for activity
|
|
What is a prosthetic group?
|
A cofactor that is very tightly bound to the enzyme
|
|
What is NADH
|
A cofact that reversibly binds to the enzyme
|
|
What is an apoenzyme
|
An ezyme minus its prosthetic group (inactive)
|
|
What is a holoenzyme
|
The enzyme containing its prosthetic group (active)
|
|
The substrate S and enzyme E combine to form ____
|
a complex ES
|
|
____ binds more tightly to enzymes than do substrates
|
transition states
|
|
What often make good therapeutic drugs?
|
transition states
|
|
What causes the formation of the transition state
|
binding of the substrate to the active site promotes straining so that the transition state is formed
|
|
How can competitive inhibition be overcome?
|
Increase the substrate
|
|
What does the majority of drug metabolism
|
cytochrome P450
|
|
What is in the endoplasmic reticulum cytochrome p450 reductase?
|
FAD and FMN. FAD is the electron entry site, FMN is the electron exit site.
Cytochrome b5 - a small heme protein that can be involved in the electron transfer |
|
What is in the mitochondrial P450 system?
|
Steroid hydroxylation reaction
cytochrome P450, NADH and FAD. FAD is weakly associated and needs Adrenodoxin-two Fe-S clusters. |
|
How is P450 classified into familes and subfamilies?
|
Based on amino acid sequences?
|
|
Family members that share a 40% sequence homology are assigned a ___
|
number
|
|
Family members that share a 55% -99% homology are assigned ___
|
a subletter
|
|
How does alcohol affect CYP
|
alcohol induces CYP
|
|
What is the primary endogenous vasodilator?
|
NO
|
|
What is NO necessary for?
|
maintenance of vascular tone, platelet aggregation, and neural transmission
|
|
What is nNOS
|
neuronal NOS - skeletal muscle and neurons
|
|
What is NOSII
|
iNOS - macrophage or induced
|
|
What is NOSIII
|
eNOS - endothelium (myristoylation, palmitoylation)
|
|
What do all three isoforms of NO contain?
|
a heme prosthetic group, FAD, and FMN, and tetrahydrobiopterin
|
|
What is the electron donor for NO?
|
NADH - electrons enter via FAD and exit FMN
|
|
What is calmodulin
|
a calcium binding protein - controls the flow of electrons from FMN to the heme
|
|
What elements are required for NOS to have effect?
|
Iron, zinc, calcium
|
|
What is eNOS
|
important for blood vessel tone, overproduction can cause hypertension and thrombosis, can be beneficial as a treatment for pulmonary arterial hypertension
|
|
What is iNOS
|
essential in tumorcidal and bacterialicidal functions of macrophage
|
|
What is nNOS
|
shows loss of control of intestinal muscle and resistance to ischemic injury, producing vascular stroke
|
|
What NOS is dependent upon calcium?
|
eNOS and nNOS
|
|
What NOS is independent of calcium
|
iNOS
|